

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of mesoderm development (GO:2000380) | 4.37667592 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.13957270 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.13957270 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.03610760 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.03610760 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 3.92761959 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.92678489 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 3.92678489 |
| 9 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.92619470 |
| 10 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.90171009 |
| 11 | somite rostral/caudal axis specification (GO:0032525) | 3.89415886 |
| 12 | mitotic G2/M transition checkpoint (GO:0044818) | 3.89391835 |
| 13 | CENP-A containing nucleosome assembly (GO:0034080) | 3.86420659 |
| 14 | female gonad development (GO:0008585) | 3.83043102 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 3.81496885 |
| 16 | anterior/posterior axis specification, embryo (GO:0008595) | 3.81394466 |
| 17 | cell migration involved in gastrulation (GO:0042074) | 3.80494388 |
| 18 | cysteine metabolic process (GO:0006534) | 3.78947072 |
| 19 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.76510505 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 3.68259260 |
| 21 | chromatin remodeling at centromere (GO:0031055) | 3.67802182 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66176804 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66176804 |
| 24 | lysine metabolic process (GO:0006553) | 3.64083045 |
| 25 | lysine catabolic process (GO:0006554) | 3.64083045 |
| 26 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.62183586 |
| 27 | phospholipid scrambling (GO:0017121) | 3.60119853 |
| 28 | nodal signaling pathway (GO:0038092) | 3.59569285 |
| 29 | anterior/posterior axis specification (GO:0009948) | 3.58145048 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.56243480 |
| 31 | negative regulation of activin receptor signaling pathway (GO:0032926) | 3.56056878 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.52997969 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.46379507 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 3.44593966 |
| 35 | regulation of cholesterol homeostasis (GO:2000188) | 3.43608954 |
| 36 | histone exchange (GO:0043486) | 3.39370417 |
| 37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.39186721 |
| 38 | urea cycle (GO:0000050) | 3.37455463 |
| 39 | urea metabolic process (GO:0019627) | 3.37455463 |
| 40 | DNA double-strand break processing (GO:0000729) | 3.37185328 |
| 41 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.35966349 |
| 42 | complement activation, alternative pathway (GO:0006957) | 3.35705153 |
| 43 | histone mRNA catabolic process (GO:0071044) | 3.34900030 |
| 44 | kynurenine metabolic process (GO:0070189) | 3.34860342 |
| 45 | positive regulation of histone deacetylation (GO:0031065) | 3.34285665 |
| 46 | valine metabolic process (GO:0006573) | 3.33790242 |
| 47 | positive regulation of protein autophosphorylation (GO:0031954) | 3.29645363 |
| 48 | protein carboxylation (GO:0018214) | 3.29598981 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.29598981 |
| 50 | homocysteine metabolic process (GO:0050667) | 3.28645698 |
| 51 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.28267751 |
| 52 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.27942194 |
| 53 | indole-containing compound catabolic process (GO:0042436) | 3.27857138 |
| 54 | indolalkylamine catabolic process (GO:0046218) | 3.27857138 |
| 55 | tryptophan catabolic process (GO:0006569) | 3.27857138 |
| 56 | dorsal/ventral axis specification (GO:0009950) | 3.25988771 |
| 57 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.25438021 |
| 58 | phospholipid homeostasis (GO:0055091) | 3.25105412 |
| 59 | tryptophan metabolic process (GO:0006568) | 3.24084783 |
| 60 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23000795 |
| 61 | primitive streak formation (GO:0090009) | 3.20153451 |
| 62 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.19573553 |
| 63 | hepatocyte apoptotic process (GO:0097284) | 3.17090140 |
| 64 | gastrulation (GO:0007369) | 3.16051299 |
| 65 | drug transmembrane transport (GO:0006855) | 3.14997733 |
| 66 | regulation of protein activation cascade (GO:2000257) | 3.12933391 |
| 67 | COPII vesicle coating (GO:0048208) | 3.12584714 |
| 68 | glyoxylate metabolic process (GO:0046487) | 3.12173240 |
| 69 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06524064 |
| 70 | nucleotide-sugar metabolic process (GO:0009225) | 3.03783644 |
| 71 | bile acid biosynthetic process (GO:0006699) | 3.03257335 |
| 72 | regulation of metalloenzyme activity (GO:0048552) | 3.03090224 |
| 73 | negative regulation of cell fate specification (GO:0009996) | 3.02791658 |
| 74 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.02308868 |
| 75 | DNA replication-independent nucleosome organization (GO:0034724) | 3.02308868 |
| 76 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.01183018 |
| 77 | regulation of fibrinolysis (GO:0051917) | 3.01014421 |
| 78 | proteasome assembly (GO:0043248) | 3.00430226 |
| 79 | protein neddylation (GO:0045116) | 2.98912103 |
| 80 | regulation of complement activation (GO:0030449) | 2.98760886 |
| 81 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.98544172 |
| 82 | bile acid and bile salt transport (GO:0015721) | 2.97945182 |
| 83 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.97888048 |
| 84 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.97869527 |
| 85 | regulation of triglyceride catabolic process (GO:0010896) | 2.97834087 |
| 86 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.96976416 |
| 87 | nitrogen cycle metabolic process (GO:0071941) | 2.96871190 |
| 88 | mesodermal cell differentiation (GO:0048333) | 2.96621249 |
| 89 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.96329010 |
| 90 | nuclear pore complex assembly (GO:0051292) | 2.95527626 |
| 91 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.95334210 |
| 92 | bile acid metabolic process (GO:0008206) | 2.95279356 |
| 93 | intestinal cholesterol absorption (GO:0030299) | 2.95022336 |
| 94 | regulation of cell fate specification (GO:0042659) | 2.94773825 |
| 95 | mitotic sister chromatid cohesion (GO:0007064) | 2.94626894 |
| 96 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.92990152 |
| 97 | high-density lipoprotein particle remodeling (GO:0034375) | 2.92214828 |
| 98 | negative regulation of cholesterol transport (GO:0032375) | 2.90846277 |
| 99 | negative regulation of sterol transport (GO:0032372) | 2.90846277 |
| 100 | positive regulation of nuclease activity (GO:0032075) | 2.89973874 |
| 101 | regulation of sulfur metabolic process (GO:0042762) | 2.89670700 |
| 102 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.89599041 |
| 103 | isotype switching (GO:0045190) | 2.89599041 |
| 104 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.89599041 |
| 105 | response to X-ray (GO:0010165) | 2.89360511 |
| 106 | ethanol oxidation (GO:0006069) | 2.88896270 |
| 107 | 4-hydroxyproline metabolic process (GO:0019471) | 2.87693354 |
| 108 | intestinal absorption (GO:0050892) | 2.87137799 |
| 109 | negative regulation of protein activation cascade (GO:2000258) | 2.86481379 |
| 110 | phospholipid efflux (GO:0033700) | 2.84892505 |
| 111 | reverse cholesterol transport (GO:0043691) | 2.83482940 |
| 112 | regulation of gene silencing by RNA (GO:0060966) | 2.82697623 |
| 113 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.82697623 |
| 114 | regulation of gene silencing by miRNA (GO:0060964) | 2.82697623 |
| 115 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.81887603 |
| 116 | regulation of coenzyme metabolic process (GO:0051196) | 2.81662153 |
| 117 | regulation of cofactor metabolic process (GO:0051193) | 2.81662153 |
| 118 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.80737386 |
| 119 | resolution of meiotic recombination intermediates (GO:0000712) | 2.79941378 |
| 120 | nuclear pore organization (GO:0006999) | 2.79004948 |
| 121 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.78621335 |
| 122 | kidney morphogenesis (GO:0060993) | 2.74892226 |
| 123 | cellular glucuronidation (GO:0052695) | 2.74411782 |
| 124 | negative regulation of complement activation (GO:0045916) | 2.73807569 |
| 125 | lipoprotein metabolic process (GO:0042157) | 2.73161978 |
| 126 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.72718322 |
| 127 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.72314110 |
| 128 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.72314110 |
| 129 | plasma lipoprotein particle assembly (GO:0034377) | 2.72305502 |
| 130 | prenylation (GO:0097354) | 2.72100055 |
| 131 | protein prenylation (GO:0018342) | 2.72100055 |
| 132 | protein-lipid complex assembly (GO:0065005) | 2.72027219 |
| 133 | synapsis (GO:0007129) | 2.71297388 |
| 134 | regulation of helicase activity (GO:0051095) | 2.71242017 |
| 135 | tricarboxylic acid metabolic process (GO:0072350) | 2.71163637 |
| 136 | positive regulation of glycolytic process (GO:0045821) | 2.71138995 |
| 137 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.70099906 |
| 138 | 2-oxoglutarate metabolic process (GO:0006103) | 2.69755235 |
| 139 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.69204725 |
| 140 | positive regulation of B cell differentiation (GO:0045579) | 2.67240402 |
| 141 | regulation of nuclease activity (GO:0032069) | 2.66314170 |
| 142 | plasma lipoprotein particle clearance (GO:0034381) | 2.66013629 |
| 143 | amino-acid betaine metabolic process (GO:0006577) | 2.65942348 |
| 144 | tyrosine metabolic process (GO:0006570) | 2.65813505 |
| 145 | embryonic axis specification (GO:0000578) | 2.65153121 |
| 146 | growth hormone receptor signaling pathway (GO:0060396) | 2.65125186 |
| 147 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.64648555 |
| 148 | non-recombinational repair (GO:0000726) | 2.64648555 |
| 149 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.63886367 |
| 150 | DNA ligation (GO:0006266) | 2.63567766 |
| 151 | regulation of superoxide anion generation (GO:0032928) | 2.62979834 |
| 152 | triglyceride homeostasis (GO:0070328) | 2.62673761 |
| 153 | acylglycerol homeostasis (GO:0055090) | 2.62673761 |
| 154 | regulation of DNA endoreduplication (GO:0032875) | 2.61208249 |
| 155 | protein localization to kinetochore (GO:0034501) | 2.61063367 |
| 156 | regulation of apoptotic cell clearance (GO:2000425) | 2.60546785 |
| 157 | serine family amino acid catabolic process (GO:0009071) | 2.59999861 |
| 158 | cellular modified amino acid catabolic process (GO:0042219) | 2.59719290 |
| 159 | urate metabolic process (GO:0046415) | 2.58585277 |
| 160 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.57969505 |
| 161 | positive regulation of lipid catabolic process (GO:0050996) | 2.57955588 |
| 162 | low-density lipoprotein particle remodeling (GO:0034374) | 2.56198580 |
| 163 | hormone catabolic process (GO:0042447) | 2.56094154 |
| 164 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.55890259 |
| 165 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.55890259 |
| 166 | aromatic amino acid family metabolic process (GO:0009072) | 2.55239613 |
| 167 | epoxygenase P450 pathway (GO:0019373) | 2.54822779 |
| 168 | pre-miRNA processing (GO:0031054) | 2.54333670 |
| 169 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.54044004 |
| 170 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.53276493 |
| 171 | regulation of centriole replication (GO:0046599) | 2.52699972 |
| 172 | embryonic foregut morphogenesis (GO:0048617) | 2.52415260 |
| 173 | regulation of sister chromatid cohesion (GO:0007063) | 2.52331132 |
| 174 | negative regulation of DNA recombination (GO:0045910) | 2.51443336 |
| 175 | cellular response to unfolded protein (GO:0034620) | 2.51423584 |
| 176 | fatty acid oxidation (GO:0019395) | 2.50940807 |
| 177 | complement activation, classical pathway (GO:0006958) | 2.49356204 |
| 178 | ER-nucleus signaling pathway (GO:0006984) | 2.49302869 |
| 179 | fatty acid beta-oxidation (GO:0006635) | 2.48755989 |
| 180 | sequestering of metal ion (GO:0051238) | 2.47889853 |
| 181 | protein-lipid complex remodeling (GO:0034368) | 2.47136666 |
| 182 | macromolecular complex remodeling (GO:0034367) | 2.47136666 |
| 183 | plasma lipoprotein particle remodeling (GO:0034369) | 2.47136666 |
| 184 | low-density lipoprotein particle clearance (GO:0034383) | 2.46664980 |
| 185 | regulation of cell fate commitment (GO:0010453) | 2.46339585 |
| 186 | histone mRNA metabolic process (GO:0008334) | 2.46324408 |
| 187 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.45700622 |
| 188 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.45237870 |
| 189 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.45018192 |
| 190 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.45018192 |
| 191 | ribosome assembly (GO:0042255) | 2.44524758 |
| 192 | erythrocyte maturation (GO:0043249) | 2.44362695 |
| 193 | lipid oxidation (GO:0034440) | 2.43996440 |
| 194 | regulation of chromatin silencing (GO:0031935) | 2.43729358 |
| 195 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.43468851 |
| 196 | mitochondrial DNA replication (GO:0006264) | 2.43362591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.42289214 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.63326605 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.22246345 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92817290 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.59501889 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.58265175 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.14004058 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.11182603 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.92497848 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.81206329 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.71502246 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.70207435 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.62934511 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.41971647 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.40105711 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38539166 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.36842365 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.35596154 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.31582719 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27878954 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.22229672 |
| 22 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.20274222 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.19354024 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16863760 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.10590560 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09470001 |
| 27 | * EWS_26573619_Chip-Seq_HEK293_Human | 2.07570284 |
| 28 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.90219477 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.88288776 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88211965 |
| 31 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.87078740 |
| 32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81909097 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.80942978 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79547009 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.79178328 |
| 36 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.74693610 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71923392 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71800839 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.70884723 |
| 40 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.70573098 |
| 41 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.70304049 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70176963 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.66384450 |
| 44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.65364869 |
| 45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65141851 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64550465 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.64316459 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.63245962 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63212375 |
| 50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.63097163 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61404665 |
| 52 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.60372192 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59779201 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59385627 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59040119 |
| 56 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.59000523 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55425685 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52479770 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52003244 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50306900 |
| 61 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49704183 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.49553173 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49405069 |
| 64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49031534 |
| 65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47875473 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47357183 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46687352 |
| 68 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46606783 |
| 69 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45738662 |
| 70 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45453141 |
| 71 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45401456 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45337656 |
| 73 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.45176588 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43437022 |
| 75 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.43409569 |
| 76 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.42612291 |
| 77 | MAF_26560356_Chip-Seq_TH1_Human | 1.42415486 |
| 78 | MYB_26560356_Chip-Seq_TH1_Human | 1.41807498 |
| 79 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41732081 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41179069 |
| 81 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40909099 |
| 82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40598453 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40482492 |
| 84 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.40208032 |
| 85 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39755045 |
| 86 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39259619 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.38039755 |
| 88 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37627364 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37115094 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.36402398 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.36337613 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36082501 |
| 93 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.35184628 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33261189 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32773220 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.32235692 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31614260 |
| 98 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31230663 |
| 99 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30897712 |
| 100 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.30810450 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29987352 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29232933 |
| 103 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28748789 |
| 104 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.28012709 |
| 105 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26041399 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25422273 |
| 107 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.24978073 |
| 108 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.24821409 |
| 109 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.24222842 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22838090 |
| 111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22462789 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22459548 |
| 113 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21570113 |
| 114 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21570113 |
| 115 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19765751 |
| 116 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19675023 |
| 117 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17225507 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17179887 |
| 119 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17037678 |
| 120 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.16385819 |
| 121 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15672783 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15230672 |
| 123 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15049741 |
| 124 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.14768255 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13860461 |
| 126 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.13293760 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12644849 |
| 128 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11730218 |
| 129 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11551019 |
| 130 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11475703 |
| 131 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11475703 |
| 132 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11251217 |
| 133 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10666161 |
| 134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10396834 |
| 135 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10305604 |
| 136 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10182091 |
| 137 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09719078 |
| 138 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.09537114 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07177048 |
| 140 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07077360 |
| 141 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07007798 |
| 142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06856093 |
| 143 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06183254 |
| 144 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05974868 |
| 145 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05636695 |
| 146 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05631709 |
| 147 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05398492 |
| 148 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05359528 |
| 149 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04952726 |
| 150 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04952726 |
| 151 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04952726 |
| 152 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04665448 |
| 153 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04551105 |
| 154 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04195924 |
| 155 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04130060 |
| 156 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02827441 |
| 157 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02394724 |
| 158 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02084238 |
| 159 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01908734 |
| 160 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00044450 |
| 161 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.99977279 |
| 162 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99091122 |
| 163 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.98995189 |
| 164 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98680861 |
| 165 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.98630914 |
| 166 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.98566547 |
| 167 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.98340863 |
| 168 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97997659 |
| 169 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97766228 |
| 170 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.97688222 |
| 171 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97547917 |
| 172 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97547917 |
| 173 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97427675 |
| 174 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.97125358 |
| 175 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96597236 |
| 176 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95753101 |
| 177 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95618580 |
| 178 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95588814 |
| 179 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95547588 |
| 180 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94710573 |
| 181 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94094865 |
| 182 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92238907 |
| 183 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.91894966 |
| 184 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91734486 |
| 185 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91026749 |
| 186 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90756838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003890_abnormal_embryonic-extraembry | 5.22896414 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.62860306 |
| 3 | * MP0006054_spinal_hemorrhage | 4.38076775 |
| 4 | MP0005360_urolithiasis | 4.10967510 |
| 5 | MP0005365_abnormal_bile_salt | 3.59039789 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.42894488 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.11097224 |
| 8 | MP0003950_abnormal_plasma_membrane | 3.10542410 |
| 9 | MP0008057_abnormal_DNA_replication | 2.94517076 |
| 10 | MP0003252_abnormal_bile_duct | 2.91185894 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.85572314 |
| 12 | MP0009697_abnormal_copulation | 2.78774710 |
| 13 | MP0003941_abnormal_skin_development | 2.64542885 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.48653013 |
| 15 | MP0003122_maternal_imprinting | 2.46553039 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.31805727 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.29087596 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.19145951 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.17286256 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.15365260 |
| 21 | MP0004272_abnormal_basement_membrane | 2.09899982 |
| 22 | MP0010329_abnormal_lipoprotein_level | 2.01188039 |
| 23 | MP0002166_altered_tumor_susceptibility | 1.99560011 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.95783885 |
| 25 | MP0003195_calcinosis | 1.88356409 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.86144418 |
| 27 | MP0008058_abnormal_DNA_repair | 1.85746921 |
| 28 | MP0010094_abnormal_chromosome_stability | 1.84100836 |
| 29 | * MP0001915_intracranial_hemorrhage | 1.80892017 |
| 30 | MP0004147_increased_porphyrin_level | 1.78051673 |
| 31 | MP0003567_abnormal_fetal_cardiomyocyte | 1.75459936 |
| 32 | MP0000569_abnormal_digit_pigmentation | 1.73793954 |
| 33 | MP0005083_abnormal_biliary_tract | 1.72896831 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.72208550 |
| 35 | MP0000609_abnormal_liver_physiology | 1.71615040 |
| 36 | MP0003718_maternal_effect | 1.69522401 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.68349299 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.68294325 |
| 39 | MP0003868_abnormal_feces_composition | 1.62530750 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.61330664 |
| 41 | MP0003121_genomic_imprinting | 1.54393864 |
| 42 | MP0009840_abnormal_foam_cell | 1.53934927 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.53036937 |
| 44 | * MP0009643_abnormal_urine_homeostasis | 1.43018928 |
| 45 | MP0000516_abnormal_urinary_system | 1.42777834 |
| 46 | MP0005367_renal/urinary_system_phenotyp | 1.42777834 |
| 47 | MP0004947_skin_inflammation | 1.40903091 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.39270875 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.38546645 |
| 50 | MP0005380_embryogenesis_phenotype | 1.38534156 |
| 51 | MP0001672_abnormal_embryogenesis/_devel | 1.38534156 |
| 52 | MP0003303_peritoneal_inflammation | 1.38385772 |
| 53 | MP0008932_abnormal_embryonic_tissue | 1.36421495 |
| 54 | MP0002084_abnormal_developmental_patter | 1.33023886 |
| 55 | MP0000685_abnormal_immune_system | 1.33001513 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 1.31955471 |
| 57 | MP0003937_abnormal_limbs/digits/tail_de | 1.31560166 |
| 58 | * MP0005332_abnormal_amino_acid | 1.31459754 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.29214875 |
| 60 | MP0005387_immune_system_phenotype | 1.27163900 |
| 61 | MP0001790_abnormal_immune_system | 1.27163900 |
| 62 | MP0003119_abnormal_digestive_system | 1.26493475 |
| 63 | MP0002006_tumorigenesis | 1.25963256 |
| 64 | MP0003436_decreased_susceptibility_to | 1.25232886 |
| 65 | MP0001800_abnormal_humoral_immune | 1.25203802 |
| 66 | MP0002086_abnormal_extraembryonic_tissu | 1.23861301 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.23288075 |
| 68 | MP0001730_embryonic_growth_arrest | 1.22385378 |
| 69 | MP0003984_embryonic_growth_retardation | 1.19795462 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.18133643 |
| 71 | MP0002088_abnormal_embryonic_growth/wei | 1.17848355 |
| 72 | MP0001697_abnormal_embryo_size | 1.17770829 |
| 73 | MP0003111_abnormal_nucleus_morphology | 1.17143269 |
| 74 | MP0001879_abnormal_lymphatic_vessel | 1.16537025 |
| 75 | MP0003786_premature_aging | 1.15963890 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.14982330 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 1.13365404 |
| 78 | MP0003943_abnormal_hepatobiliary_system | 1.09863772 |
| 79 | MP0001944_abnormal_pancreas_morphology | 1.08681528 |
| 80 | MP0005395_other_phenotype | 1.07884864 |
| 81 | MP0000598_abnormal_liver_morphology | 1.07538759 |
| 82 | MP0001293_anophthalmia | 1.07360203 |
| 83 | MP0002928_abnormal_bile_duct | 1.05933861 |
| 84 | MP0001286_abnormal_eye_development | 1.05802555 |
| 85 | MP0001873_stomach_inflammation | 1.04811827 |
| 86 | MP0001835_abnormal_antigen_presentation | 1.04073872 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 1.03980917 |
| 88 | MP0002060_abnormal_skin_morphology | 1.02672716 |
| 89 | MP0000013_abnormal_adipose_tissue | 1.01520978 |
| 90 | MP0003077_abnormal_cell_cycle | 1.01256410 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.98389769 |
| 92 | * MP0002136_abnormal_kidney_physiology | 0.97409265 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 0.97154242 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.96944832 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.96903701 |
| 96 | MP0005174_abnormal_tail_pigmentation | 0.95711483 |
| 97 | MP0008004_abnormal_stomach_pH | 0.95055021 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.94893213 |
| 99 | MP0002938_white_spotting | 0.94718617 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.94523919 |
| 101 | MP0004043_abnormal_pH_regulation | 0.94511310 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.93565490 |
| 103 | MP0002452_abnormal_antigen_presenting | 0.93309091 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.92555175 |
| 105 | MP0003183_abnormal_peptide_metabolism | 0.92496545 |
| 106 | MP0003866_abnormal_defecation | 0.92155792 |
| 107 | * MP0001845_abnormal_inflammatory_respons | 0.91384762 |
| 108 | MP0001756_abnormal_urination | 0.91214746 |
| 109 | MP0002009_preneoplasia | 0.90846611 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.90263666 |
| 111 | MP0005023_abnormal_wound_healing | 0.87859646 |
| 112 | MP0005408_hypopigmentation | 0.87829289 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.86991206 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86873002 |
| 115 | MP0004130_abnormal_muscle_cell | 0.86695526 |
| 116 | MP0008438_abnormal_cutaneous_collagen | 0.85892786 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.85856473 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.85705384 |
| 119 | MP0004808_abnormal_hematopoietic_stem | 0.85413118 |
| 120 | MP0009780_abnormal_chondrocyte_physiolo | 0.85117208 |
| 121 | MP0009278_abnormal_bone_marrow | 0.85106071 |
| 122 | MP0002085_abnormal_embryonic_tissue | 0.84598150 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.84383901 |
| 124 | MP0008469_abnormal_protein_level | 0.84023531 |
| 125 | MP0000428_abnormal_craniofacial_morphol | 0.83792539 |
| 126 | MP0002254_reproductive_system_inflammat | 0.83056041 |
| 127 | MP0005275_abnormal_skin_tensile | 0.82789163 |
| 128 | MP0005075_abnormal_melanosome_morpholog | 0.80931139 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.80638579 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.80092868 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.79395188 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.78825910 |
| 133 | MP0002896_abnormal_bone_mineralization | 0.78361881 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.78214881 |
| 135 | MP0000689_abnormal_spleen_morphology | 0.78175255 |
| 136 | * MP0002398_abnormal_bone_marrow | 0.77607259 |
| 137 | MP0002723_abnormal_immune_serum | 0.77232529 |
| 138 | MP0000358_abnormal_cell_content/ | 0.76720583 |
| 139 | MP0003385_abnormal_body_wall | 0.76108822 |
| 140 | MP0000465_gastrointestinal_hemorrhage | 0.74507119 |
| 141 | MP0002420_abnormal_adaptive_immunity | 0.74480237 |
| 142 | MP0005000_abnormal_immune_tolerance | 0.74217490 |
| 143 | MP0003045_fibrosis | 0.74209611 |
| 144 | MP0002111_abnormal_tail_morphology | 0.74163352 |
| 145 | MP0000767_abnormal_smooth_muscle | 0.74109664 |
| 146 | MP0003186_abnormal_redox_activity | 0.73522204 |
| 147 | MP0000350_abnormal_cell_proliferation | 0.73481027 |
| 148 | MP0001819_abnormal_immune_cell | 0.72811132 |
| 149 | MP0010307_abnormal_tumor_latency | 0.72686535 |
| 150 | MP0002722_abnormal_immune_system | 0.72265569 |
| 151 | MP0009703_decreased_birth_body | 0.71890317 |
| 152 | MP0008260_abnormal_autophagy | 0.71745751 |
| 153 | MP0000477_abnormal_intestine_morphology | 0.71631696 |
| 154 | MP0000716_abnormal_immune_system | 0.70559054 |
| 155 | MP0005334_abnormal_fat_pad | 0.70168204 |
| 156 | MP0002168_other_aberrant_phenotype | 0.69736072 |
| 157 | MP0001661_extended_life_span | 0.69520553 |
| 158 | MP0002909_abnormal_adrenal_gland | 0.69446503 |
| 159 | MP0009763_increased_sensitivity_to | 0.69390221 |
| 160 | * MP0002080_prenatal_lethality | 0.69127667 |
| 161 | MP0003172_abnormal_lysosome_physiology | 0.68560724 |
| 162 | * MP0002925_abnormal_cardiovascular_devel | 0.67960572 |
| 163 | MP0004133_heterotaxia | 0.67735106 |
| 164 | MP0002233_abnormal_nose_morphology | 0.67489313 |
| 165 | MP0005384_cellular_phenotype | 0.66501038 |
| 166 | MP0000432_abnormal_head_morphology | 0.62902110 |
| 167 | MP0000427_abnormal_hair_cycle | 0.62686671 |
| 168 | * MP0001119_abnormal_female_reproductive | 0.61511717 |
| 169 | MP0002163_abnormal_gland_morphology | 0.60536318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.25608658 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.14489897 |
| 3 | Hypoglycemic coma (HP:0001325) | 3.77155637 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.69947496 |
| 5 | Xanthomatosis (HP:0000991) | 3.59600394 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.52996412 |
| 7 | Abnormality of the common coagulation pathway (HP:0010990) | 3.31629170 |
| 8 | Biliary tract neoplasm (HP:0100574) | 3.24792322 |
| 9 | Abnormality of chromosome stability (HP:0003220) | 3.19096170 |
| 10 | Verrucae (HP:0200043) | 3.11897057 |
| 11 | Papilloma (HP:0012740) | 3.11897057 |
| 12 | Cardiovascular calcification (HP:0011915) | 3.04695476 |
| 13 | Small epiphyses (HP:0010585) | 3.03136975 |
| 14 | Vascular calcification (HP:0004934) | 2.97593400 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 2.96785296 |
| 16 | Hypoplasia of the thymus (HP:0000778) | 2.94716964 |
| 17 | Hypoglycemic seizures (HP:0002173) | 2.93841374 |
| 18 | Mitral stenosis (HP:0001718) | 2.93604156 |
| 19 | Papillary thyroid carcinoma (HP:0002895) | 2.93464778 |
| 20 | Meckel diverticulum (HP:0002245) | 2.92009611 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 2.92008298 |
| 22 | Complement deficiency (HP:0004431) | 2.83438343 |
| 23 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.82254772 |
| 24 | Myocardial infarction (HP:0001658) | 2.79391878 |
| 25 | Abnormality of oral frenula (HP:0000190) | 2.79108267 |
| 26 | Abnormal auditory evoked potentials (HP:0006958) | 2.76436697 |
| 27 | Chromsome breakage (HP:0040012) | 2.75264846 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 2.75069561 |
| 29 | B lymphocytopenia (HP:0010976) | 2.73593910 |
| 30 | Abnormality of B cell number (HP:0010975) | 2.73593910 |
| 31 | Abnormality of the ileum (HP:0001549) | 2.73172187 |
| 32 | Methylmalonic acidemia (HP:0002912) | 2.72244462 |
| 33 | Ketosis (HP:0001946) | 2.70226225 |
| 34 | Ketoacidosis (HP:0001993) | 2.70162419 |
| 35 | Embryonal renal neoplasm (HP:0011794) | 2.69624979 |
| 36 | T lymphocytopenia (HP:0005403) | 2.69506603 |
| 37 | Bifid tongue (HP:0010297) | 2.67527063 |
| 38 | Supernumerary spleens (HP:0009799) | 2.65993661 |
| 39 | Recurrent viral infections (HP:0004429) | 2.64760091 |
| 40 | Epidermoid cyst (HP:0200040) | 2.64372465 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63394302 |
| 42 | Gonadal dysgenesis (HP:0000133) | 2.62528249 |
| 43 | Agammaglobulinemia (HP:0004432) | 2.62235732 |
| 44 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.61843871 |
| 45 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.61843871 |
| 46 | Poikilocytosis (HP:0004447) | 2.61603747 |
| 47 | Abnormality of T cell number (HP:0011839) | 2.57927882 |
| 48 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.57450830 |
| 49 | Abnormal biliary tract morphology (HP:0012440) | 2.57250921 |
| 50 | Disproportionate short-trunk short stature (HP:0003521) | 2.57137956 |
| 51 | Fat malabsorption (HP:0002630) | 2.55251873 |
| 52 | Cellulitis (HP:0100658) | 2.52141079 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.51129331 |
| 54 | Prolonged partial thromboplastin time (HP:0003645) | 2.49278629 |
| 55 | Neoplasm of the small intestine (HP:0100833) | 2.46847462 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.44961583 |
| 57 | Acanthocytosis (HP:0001927) | 2.44563013 |
| 58 | Hyperlipoproteinemia (HP:0010980) | 2.43389851 |
| 59 | Ankyloglossia (HP:0010296) | 2.43020386 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.42882496 |
| 61 | Colitis (HP:0002583) | 2.39868947 |
| 62 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.39123846 |
| 63 | Thyroid carcinoma (HP:0002890) | 2.38291007 |
| 64 | Abnormality of vitamin B metabolism (HP:0004340) | 2.35894823 |
| 65 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.33799746 |
| 66 | Subacute progressive viral hepatitis (HP:0006572) | 2.32648285 |
| 67 | Thyroiditis (HP:0100646) | 2.31625727 |
| 68 | Hyperglycemia (HP:0003074) | 2.31321381 |
| 69 | Esophageal varix (HP:0002040) | 2.30860963 |
| 70 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.29505337 |
| 71 | Joint hemorrhage (HP:0005261) | 2.28728472 |
| 72 | Symptomatic seizures (HP:0011145) | 2.27297546 |
| 73 | Hypoalphalipoproteinemia (HP:0003233) | 2.25428560 |
| 74 | Gout (HP:0001997) | 2.23613465 |
| 75 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21326429 |
| 76 | Late onset (HP:0003584) | 2.19109204 |
| 77 | Abnormal foot bone ossification (HP:0010675) | 2.19047247 |
| 78 | Anal stenosis (HP:0002025) | 2.18922242 |
| 79 | Ulnar bowing (HP:0003031) | 2.16192979 |
| 80 | Volvulus (HP:0002580) | 2.15108298 |
| 81 | Hematochezia (HP:0002573) | 2.14796953 |
| 82 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.14795962 |
| 83 | Ovarian neoplasm (HP:0100615) | 2.14425087 |
| 84 | Epiphyseal dysplasia (HP:0002656) | 2.14275206 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.14040555 |
| 86 | Neoplasm of the rectum (HP:0100743) | 2.13047419 |
| 87 | Abnormal lung lobation (HP:0002101) | 2.13027405 |
| 88 | Hypophosphatemic rickets (HP:0004912) | 2.12499869 |
| 89 | Aortic aneurysm (HP:0004942) | 2.11783178 |
| 90 | Abnormality of the preputium (HP:0100587) | 2.10724852 |
| 91 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.09455492 |
| 92 | Gastrointestinal carcinoma (HP:0002672) | 2.09455492 |
| 93 | Skin nodule (HP:0200036) | 2.08926821 |
| 94 | Spastic diplegia (HP:0001264) | 2.08864338 |
| 95 | Hyperammonemia (HP:0001987) | 2.08828076 |
| 96 | Irregular epiphyses (HP:0010582) | 2.08806102 |
| 97 | Rectal fistula (HP:0100590) | 2.07869551 |
| 98 | Rectovaginal fistula (HP:0000143) | 2.07869551 |
| 99 | Abnormality of complement system (HP:0005339) | 2.06557179 |
| 100 | Facial diplegia (HP:0001349) | 2.06523857 |
| 101 | Macroorchidism (HP:0000053) | 2.06178099 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.05201606 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.04914250 |
| 104 | Increased mean platelet volume (HP:0011877) | 2.04750718 |
| 105 | Renal cortical cysts (HP:0000803) | 2.04537519 |
| 106 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.03035352 |
| 107 | Colon cancer (HP:0003003) | 2.02379292 |
| 108 | Bilateral microphthalmos (HP:0007633) | 2.01357984 |
| 109 | Abnormality of nucleobase metabolism (HP:0010932) | 2.01217664 |
| 110 | Abnormal platelet volume (HP:0011876) | 2.01177340 |
| 111 | Intestinal atresia (HP:0011100) | 2.00690505 |
| 112 | Back pain (HP:0003418) | 2.00660270 |
| 113 | Hyperbilirubinemia (HP:0002904) | 1.99838532 |
| 114 | Uterine neoplasm (HP:0010784) | 1.98269126 |
| 115 | Rhabdomyosarcoma (HP:0002859) | 1.96798814 |
| 116 | Abnormality of methionine metabolism (HP:0010901) | 1.96226321 |
| 117 | Progressive inability to walk (HP:0002505) | 1.95731623 |
| 118 | Myelomeningocele (HP:0002475) | 1.94019701 |
| 119 | Abdominal distention (HP:0003270) | 1.92882649 |
| 120 | Abnormal cartilage morphology (HP:0002763) | 1.92042730 |
| 121 | Osteomyelitis (HP:0002754) | 1.91423811 |
| 122 | Hypochromic microcytic anemia (HP:0004840) | 1.91073716 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90182014 |
| 124 | Mucopolysacchariduria (HP:0008155) | 1.90182014 |
| 125 | Hypercholesterolemia (HP:0003124) | 1.89591846 |
| 126 | Hyperglycinemia (HP:0002154) | 1.89375773 |
| 127 | Gingival bleeding (HP:0000225) | 1.88429124 |
| 128 | Spontaneous abortion (HP:0005268) | 1.86547871 |
| 129 | Autoimmune thrombocytopenia (HP:0001973) | 1.85211149 |
| 130 | Short tibia (HP:0005736) | 1.84933943 |
| 131 | Abnormality of vitamin metabolism (HP:0100508) | 1.84249424 |
| 132 | Short humerus (HP:0005792) | 1.83884357 |
| 133 | Clitoromegaly (HP:0000057) | 1.83835575 |
| 134 | Increased CSF protein (HP:0002922) | 1.83769544 |
| 135 | Abnormality of the wing of the ilium (HP:0011867) | 1.82427717 |
| 136 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.82398311 |
| 137 | Short middle phalanx of the 5th finger (HP:0004220) | 1.82351691 |
| 138 | Gonadotropin excess (HP:0000837) | 1.82099819 |
| 139 | Vaginal fistula (HP:0004320) | 1.81145164 |
| 140 | Hypothermia (HP:0002045) | 1.80481082 |
| 141 | Abnormal hand bone ossification (HP:0010660) | 1.79801348 |
| 142 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.78847276 |
| 143 | Periodontitis (HP:0000704) | 1.78502395 |
| 144 | Palpitations (HP:0001962) | 1.78226930 |
| 145 | Medulloblastoma (HP:0002885) | 1.77803721 |
| 146 | Abnormality of the duodenum (HP:0002246) | 1.77032388 |
| 147 | Prolonged bleeding time (HP:0003010) | 1.76920611 |
| 148 | Methylmalonic aciduria (HP:0012120) | 1.76750656 |
| 149 | Abnormality of T cells (HP:0002843) | 1.76674734 |
| 150 | Wide nose (HP:0000445) | 1.76634039 |
| 151 | Insulin resistance (HP:0000855) | 1.75632584 |
| 152 | Abnormality of the fingertips (HP:0001211) | 1.75428908 |
| 153 | Hyperactive renin-angiotensin system (HP:0000841) | 1.75288147 |
| 154 | Combined immunodeficiency (HP:0005387) | 1.75121755 |
| 155 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.74043014 |
| 156 | Abnormal tarsal ossification (HP:0008369) | 1.73820669 |
| 157 | Micronodular cirrhosis (HP:0001413) | 1.73703451 |
| 158 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72340547 |
| 159 | Menorrhagia (HP:0000132) | 1.71866020 |
| 160 | Neoplasm of the colon (HP:0100273) | 1.71737935 |
| 161 | Panhypogammaglobulinemia (HP:0003139) | 1.71700660 |
| 162 | Polycythemia (HP:0001901) | 1.71479891 |
| 163 | Abnormality of the nasal septum (HP:0000419) | 1.70879904 |
| 164 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.70366451 |
| 165 | Mitral valve prolapse (HP:0001634) | 1.70278249 |
| 166 | Rectal prolapse (HP:0002035) | 1.70182904 |
| 167 | Protuberant abdomen (HP:0001538) | 1.69937742 |
| 168 | Abnormality of proline metabolism (HP:0010907) | 1.69806240 |
| 169 | Hydroxyprolinuria (HP:0003080) | 1.69806240 |
| 170 | Right ventricular cardiomyopathy (HP:0011663) | 1.68717696 |
| 171 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.68322815 |
| 172 | Spontaneous hematomas (HP:0007420) | 1.67940087 |
| 173 | Aneurysm (HP:0002617) | 1.67651240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 4.81610380 |
| 2 | ACVR1B | 4.23923591 |
| 3 | FRK | 3.76468998 |
| 4 | ERN1 | 3.61812900 |
| 5 | TRIB3 | 3.31297001 |
| 6 | TNIK | 3.21307263 |
| 7 | PKN2 | 2.99113811 |
| 8 | TRIM28 | 2.83646939 |
| 9 | EIF2AK3 | 2.71979148 |
| 10 | BMPR1B | 2.50908108 |
| 11 | BRSK2 | 2.44956501 |
| 12 | TAF1 | 2.40485009 |
| 13 | MKNK2 | 2.40228683 |
| 14 | EIF2AK1 | 2.37482124 |
| 15 | SIK1 | 2.18802637 |
| 16 | EEF2K | 2.13262085 |
| 17 | TAOK3 | 2.12245180 |
| 18 | WNK3 | 2.04073772 |
| 19 | GRK6 | 2.02570120 |
| 20 | PTK6 | 2.01060380 |
| 21 | FGFR4 | 1.96387276 |
| 22 | STK39 | 1.93015759 |
| 23 | MAP4K1 | 1.85444288 |
| 24 | LRRK2 | 1.85231433 |
| 25 | STK10 | 1.82709723 |
| 26 | PLK3 | 1.78805533 |
| 27 | BCR | 1.77975460 |
| 28 | PLK4 | 1.76063869 |
| 29 | SIK3 | 1.71662546 |
| 30 | STK24 | 1.71015853 |
| 31 | FGFR3 | 1.69229233 |
| 32 | LATS1 | 1.69220099 |
| 33 | PBK | 1.67142503 |
| 34 | INSRR | 1.64741052 |
| 35 | WEE1 | 1.61796810 |
| 36 | SCYL2 | 1.55382631 |
| 37 | MKNK1 | 1.53667544 |
| 38 | TTK | 1.47388669 |
| 39 | MAP3K2 | 1.45711550 |
| 40 | STK38L | 1.44492468 |
| 41 | FGFR2 | 1.43285019 |
| 42 | MST4 | 1.40332268 |
| 43 | MST1R | 1.39432074 |
| 44 | MAP3K12 | 1.38642100 |
| 45 | FLT3 | 1.37401734 |
| 46 | CDK6 | 1.36819368 |
| 47 | YES1 | 1.36741429 |
| 48 | TYK2 | 1.34281985 |
| 49 | ERBB3 | 1.34188298 |
| 50 | FGFR1 | 1.32553431 |
| 51 | CDK12 | 1.30762540 |
| 52 | PLK2 | 1.26944999 |
| 53 | BCKDK | 1.25054881 |
| 54 | JAK1 | 1.24978712 |
| 55 | ZAK | 1.23611387 |
| 56 | STK3 | 1.22527717 |
| 57 | RIPK1 | 1.17299668 |
| 58 | ITK | 1.17157536 |
| 59 | DYRK1B | 1.15122532 |
| 60 | TGFBR2 | 1.14606362 |
| 61 | NEK1 | 1.14566151 |
| 62 | PDGFRA | 1.14485102 |
| 63 | TXK | 1.13295337 |
| 64 | PIK3CG | 1.13259516 |
| 65 | CSK | 1.10046018 |
| 66 | NEK9 | 1.09856114 |
| 67 | SRPK1 | 1.09153415 |
| 68 | TSSK6 | 1.07658988 |
| 69 | HIPK2 | 1.06069747 |
| 70 | STK4 | 1.02099173 |
| 71 | PASK | 0.98334066 |
| 72 | MAP3K7 | 0.98262991 |
| 73 | JAK2 | 0.98033014 |
| 74 | OXSR1 | 0.97622792 |
| 75 | TTN | 0.96802452 |
| 76 | JAK3 | 0.95874431 |
| 77 | ZAP70 | 0.95376386 |
| 78 | BTK | 0.91559165 |
| 79 | MAPK11 | 0.91079295 |
| 80 | NUAK1 | 0.89897068 |
| 81 | EIF2AK2 | 0.89796874 |
| 82 | PNCK | 0.87646347 |
| 83 | EPHB1 | 0.86440867 |
| 84 | CDK4 | 0.83808166 |
| 85 | RPS6KB2 | 0.81913737 |
| 86 | CSF1R | 0.81414002 |
| 87 | PDGFRB | 0.80148825 |
| 88 | MELK | 0.79669886 |
| 89 | PIM1 | 0.79662679 |
| 90 | PIK3CA | 0.78869696 |
| 91 | MAP3K3 | 0.78393451 |
| 92 | CDK9 | 0.77825171 |
| 93 | BRD4 | 0.77599886 |
| 94 | CAMK1D | 0.74407031 |
| 95 | TBK1 | 0.74003233 |
| 96 | SYK | 0.72119352 |
| 97 | RET | 0.71630400 |
| 98 | PLK1 | 0.71070397 |
| 99 | EPHA3 | 0.67726783 |
| 100 | MAP3K8 | 0.67627195 |
| 101 | TRPM7 | 0.67035750 |
| 102 | MET | 0.66819609 |
| 103 | EPHA2 | 0.66168457 |
| 104 | MAP3K14 | 0.64449798 |
| 105 | RPS6KA4 | 0.63216556 |
| 106 | TGFBR1 | 0.62378102 |
| 107 | FER | 0.62026308 |
| 108 | BRSK1 | 0.61094074 |
| 109 | MAP2K1 | 0.60407364 |
| 110 | MTOR | 0.59891815 |
| 111 | PTK2 | 0.59336640 |
| 112 | CDC7 | 0.59086014 |
| 113 | DMPK | 0.58655171 |
| 114 | PRKD1 | 0.58100152 |
| 115 | MAP2K3 | 0.57240080 |
| 116 | BMPR2 | 0.56562367 |
| 117 | NEK2 | 0.55793083 |
| 118 | PRKAA2 | 0.55128964 |
| 119 | PRKCH | 0.54472557 |
| 120 | SGK3 | 0.53872252 |
| 121 | EGFR | 0.53749280 |
| 122 | ADRBK1 | 0.53322016 |
| 123 | NLK | 0.52619318 |
| 124 | PRKCE | 0.52133133 |
| 125 | MARK3 | 0.50917314 |
| 126 | HCK | 0.47836025 |
| 127 | ATM | 0.47773475 |
| 128 | CAMK1G | 0.45887986 |
| 129 | LCK | 0.45793429 |
| 130 | GRK1 | 0.45050915 |
| 131 | PRKAA1 | 0.44129398 |
| 132 | BUB1 | 0.44043777 |
| 133 | IGF1R | 0.44027286 |
| 134 | GSK3A | 0.43442678 |
| 135 | CSNK1G1 | 0.43282371 |
| 136 | TEC | 0.43253207 |
| 137 | CHUK | 0.42785593 |
| 138 | ERBB4 | 0.42760502 |
| 139 | BMX | 0.42497057 |
| 140 | PRKCQ | 0.42374940 |
| 141 | LYN | 0.41542257 |
| 142 | DYRK3 | 0.41427079 |
| 143 | PDK1 | 0.39573814 |
| 144 | INSR | 0.39542266 |
| 145 | MAPK15 | 0.38020228 |
| 146 | MAP2K2 | 0.35400871 |
| 147 | WNK4 | 0.35025630 |
| 148 | MAP3K1 | 0.34330365 |
| 149 | PRKD2 | 0.34109436 |
| 150 | WNK1 | 0.33606069 |
| 151 | PAK4 | 0.33600592 |
| 152 | PAK3 | 0.33209060 |
| 153 | ROCK2 | 0.32720604 |
| 154 | IRAK1 | 0.32572696 |
| 155 | RAF1 | 0.31329948 |
| 156 | ERBB2 | 0.30855320 |
| 157 | MAP4K2 | 0.30543582 |
| 158 | KSR1 | 0.27362415 |
| 159 | TIE1 | 0.26942018 |
| 160 | KIT | 0.25054362 |
| 161 | CSNK2A1 | 0.24817036 |
| 162 | PRKG1 | 0.22507118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.78234670 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.47203923 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35128151 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94686051 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.94291122 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.87245595 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.57244539 |
| 8 | Basal transcription factors_Homo sapiens_hsa03022 | 2.44468919 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38921666 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.36554154 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.33241026 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.27348137 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20735639 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16316090 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04065310 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.03227429 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.00794082 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.99348121 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.97534581 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.96341796 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.92350324 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.86374849 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83014198 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.72581576 |
| 25 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.70022047 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.64962816 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.62304900 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62170441 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59399812 |
| 30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.58972179 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.49640663 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.49205944 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.48971889 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.41701719 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39934045 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.37122737 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36466043 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.36298653 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35782287 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.35517493 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34537314 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34438185 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34433978 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.33803010 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33006822 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31981281 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.31110875 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30314320 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.30309674 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.30236723 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.29281450 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25161559 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24367629 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24077257 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18261596 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 1.16757627 |
| 57 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15565383 |
| 58 | RNA transport_Homo sapiens_hsa03013 | 1.14407787 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14127154 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.07063585 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06063635 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.04054832 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97330723 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95331989 |
| 65 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.92754617 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.89619045 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89480941 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88864410 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88527894 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87049262 |
| 71 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.86668390 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86301041 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83909512 |
| 74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.83649379 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81486535 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.81470889 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80917859 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80809093 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.77952071 |
| 80 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.77149604 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76406581 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75665091 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73932466 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73398040 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73295785 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72301237 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71800598 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71678660 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.71034450 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70758643 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69357134 |
| 92 | DNA replication_Homo sapiens_hsa03030 | 0.69333592 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67941984 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66328378 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66207902 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65818170 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64596806 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62546661 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61931173 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.61513908 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61016541 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60852590 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60198568 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59222558 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58661293 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.58576885 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57483414 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56862685 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56171974 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.55803550 |
| 111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54875805 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53976676 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53200659 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52206959 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52106547 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52009878 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51100594 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50788393 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.50690457 |
| 120 | * Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49863511 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.49022384 |
| 122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48573434 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48068160 |
| 124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47443949 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.47281181 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46528184 |
| 127 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46256377 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46155681 |
| 129 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45776488 |
| 130 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45120622 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44967526 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43583247 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43375198 |
| 134 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42773804 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42280111 |
| 136 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41880732 |
| 137 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41590632 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.41462668 |
| 139 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40522865 |
| 140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39707211 |
| 141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39046937 |
| 142 | Hepatitis C_Homo sapiens_hsa05160 | 0.38917665 |
| 143 | Purine metabolism_Homo sapiens_hsa00230 | 0.38715243 |
| 144 | Legionellosis_Homo sapiens_hsa05134 | 0.38559677 |
| 145 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38519349 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38210876 |
| 147 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36860351 |
| 148 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36639590 |
| 149 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34684892 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34165930 |
| 151 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34044391 |
| 152 | Hepatitis B_Homo sapiens_hsa05161 | 0.33339729 |
| 153 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33271946 |
| 154 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.31842548 |
| 155 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.31227883 |
| 156 | Base excision repair_Homo sapiens_hsa03410 | 0.30028660 |
| 157 | Tight junction_Homo sapiens_hsa04530 | 0.27986867 |

